DCF — ST. ALPHONSUS REGIONAL MED CENTER
Enterprise Value: $-1.1B
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-1.1B
Enterprise Value
$-347.9M
PV of Cash Flows
$-745.0M
PV of Terminal Value
$-1.2B
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $747.6M | $-66.9M | -9.0% | $-98.6M | $-89.6M |
| Year 2 | $770.0M | $-61.2M | -8.0% | $-93.8M | $-77.5M |
| Year 3 | $793.1M | $-55.1M | -7.0% | $-88.7M | $-66.6M |
| Year 4 | $816.9M | $-52.7M | -6.0% | $-87.3M | $-59.6M |
| Year 5 | $841.4M | $-52.2M | -6.0% | $-87.8M | $-54.5M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-1.1B. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$725.8M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.09450606011712992
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5